Flow chart of study participants. by Eva Rydahl (6260771)

Subjects:

Timeseries analyses HSJ trend before- and during intervention. by Eva Rydahl (6260771)

Subjects:

Determination of the ventilatory threshold (VT) point. by Kazufumi Hisamoto (21416905)

Subjects:

Visual examples of the change in maximum height measure. by Teagan McMahon (20108036)

Subjects:

Schematic representation of the experimental design. by Bing-Nan Zhao (21553401)

Subjects:

Cardiac function assessed by echocardiography with/without allopurinol. by Akinaka Morii (12709672)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Comparison in baseline variables between efficacy group and non-efficacy group. by Naruyoshi Gyoutoku (22537831)

Subjects:

Robustness test results. by Yanling Li (269030)

Subjects:

Integration of Metabolomics, Transcriptomics, and 16s rRNA Sequencing Reveals the Mechanism of Morus alba <i>L.</i> (Sangzhi) Alkaloids (SZ-A) in Improving Cholesterol Metabolism i... by Caina Li (4126462)

Subjects:

Results of the pathway analysis performed using the STITCH bioinformatics tool. by Bhuripit Saraphol (20855573)

Subjects:

Raw metabolomic data. by Bhuripit Saraphol (20855573)

Subjects:

Overall cardiovascular disease DALYs age-standardised rate over time 1990-2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Dynamic profile of coagulation parameters between survivors and non-survivors in patients with SFTS. by Huan Wang (109286)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Original data. by Yi Wang (32470)

Subjects:

Absolute numbers among CS groups. by Eva Rydahl (6260771)

Subjects:

Database of the incidence rates of various types of viral hepatitis in Zhejiang Province from 2004 to 2023. by Ming Xue (591840)

Subjects:

Comparison of ALT (A), AST (B), and Fib-4 index (C) before and after imeglimin treatment in ALT ≥ 25 IU/L and ALT < 25IU/L groups. by Naruyoshi Gyoutoku (22537831)

Subjects:

Multivariable Gompertz AFT model for survival status and predictors among stroke patients (n = 137). by Farayi Kaseke (19560197)

Subjects: